Nalmefene Base

Octreotide

octreotide

Somatostatin Analog [EPC]

11 DESCRIPTION MYCAPSSA delayed release capsules contain octreotide acetate, a somatostatin analog. Octreotide is known chemically as L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl) propyl]-, cyclic (2→7)-disulfide; [R-(R*,R*)].

Enterococcus Faecalis, Pneumococcinum, Streptococcus Agalactiae, Streptococcus Agalactiae Dna, Streptococcus Bovis, Streptococcus Dysgalactiae, Streptococcus Dysgalactiae Dna, Streptococcus Mutans, Streptococcus Mutans Dna, Streptococcus Oralis, Streptococcus Pneumoniae, Streptococcus Pneumoniae Dna, Streptococcus Uberis, Streptococcus Viridans

enterococcus faecalis, pneumococcinum, streptococcus agalactiae, streptococcus agalactiae dna, streptococcus bovis, streptococcus dysgalactiae, streptococcus dysgalactiae dna, streptococcus mutans, streptococcus mutans dna, streptococcus oralis, streptococcus pneumoniae, streptococcus pneumoniae dna, streptococcus uberis, streptococcus viridans

Dosage form: LIQUID. Active ingredients: ENTEROCOCCUS FAECALIS (90 [hp_X]/mL); HERRING SPERM DNA (90 [hp_X]/mL); STREPTOCOCCUS AGALACTIAE (90 [hp_X]/mL); STREPTOCOCCUS DYSGALACTIAE (90 [hp_X]/mL); STREPTOCOCCUS EQUINUS (90 [hp_X]/mL); STREPTOCOCCUS MUTANS (90 [hp_X]/mL); STREPTOCOCCUS ORALIS (90 [hp_X]/mL); STREPTOCOCCUS PNEUMONIAE (90 [hp_X]/mL); STREPTOCOCCUS UBERIS (90 [hp_X]/mL); STREPTOCOCCUS VIRIDANS GROUP (90 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.

Urofollitropin

urofollitropin

Dosage form: POWDER. Active ingredients: UROFOLLITROPIN (1000000 [iU]/1000000[iU]). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.